Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia
This study has been completed.
Study NCT00003688 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gestational Trophoblastic Tumor
Additional conditions recognized in this trial
Gestational Trophoblastic Neoplasms
Hydatidiform Mole
Trophoblastic Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Pregnancy Complications
Pregnancy Complications, Neoplastic
Interventions listed in this trial
dactinomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Gynecologic Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
